Title : LHRH receptor targeted therapy for breast cancer.

Pub. Date : 2008

PMID : 18290339






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In our studies, we conjugated Fe3O4 nanoparticles (20-30 nm) with [D-Trp6]LHRH (Triptorelin), a decapeptide analog of LHRH currently used for treatment of sex-hormone-dependent tumors. ferryl iron transient receptor potential cation channel subfamily C member 6 Homo sapiens
2 In our studies, we conjugated Fe3O4 nanoparticles (20-30 nm) with [D-Trp6]LHRH (Triptorelin), a decapeptide analog of LHRH currently used for treatment of sex-hormone-dependent tumors. ferryl iron gonadotropin releasing hormone 1 Homo sapiens
3 In our studies, we conjugated Fe3O4 nanoparticles (20-30 nm) with [D-Trp6]LHRH (Triptorelin), a decapeptide analog of LHRH currently used for treatment of sex-hormone-dependent tumors. ferryl iron gonadotropin releasing hormone 1 Homo sapiens
4 Conjugation of [D-Trp6]LHRH to Fe3O4 particles retained its binding affinity and biological activity for the LHRH receptor. ferryl iron transient receptor potential cation channel subfamily C member 6 Homo sapiens
5 Conjugation of [D-Trp6]LHRH to Fe3O4 particles retained its binding affinity and biological activity for the LHRH receptor. ferryl iron gonadotropin releasing hormone 1 Homo sapiens
6 Conjugation of [D-Trp6]LHRH to Fe3O4 particles retained its binding affinity and biological activity for the LHRH receptor. ferryl iron gonadotropin releasing hormone 1 Homo sapiens